Drugs & Aging

Papers
(The median citation count of Drugs & Aging is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot Study67
Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need58
Pharmacological Management of IgG4-Related Disease: From Traditional to Mechanism-Based Targeted Therapies44
Factors Influencing General Practitioners’ Deprescribing Decisions for Older Adults, with Insights into Frailty: a Qualitative Study in Greek Primary Care43
A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function i41
Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients39
Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update36
Sodium-Glucose Cotransporter 2 Inhibitors in Frail Patients with Heart Failure: Clinical Experience of a Heart Failure Unit36
Clinical Considerations for Insulin Therapy in Older Adults with Type 1 Diabetes34
Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults32
Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial31
The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults30
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma30
Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity29
Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis29
Ghent Older People’s Prescriptions Community Pharmacy Screening (GheOP3S)-Tool Version 2: Update of a Tool to Detect Drug-Related Problems in Older People in Primary Care28
Postoperative Pain Treatment in Patients with Dementia: A Retrospective Observational Study28
Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects26
Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over25
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study25
Optimizing Medications with the Geriatrics 5Ms: An Age-Friendly Approach24
The Information-Seeking Behavior and Unmet Knowledge Needs of Older Medicinal Cannabis Consumers in Canada: A Qualitative Descriptive Study22
Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial22
Trends, Patterns and Associated User Characteristics of Antidepressant Prescriptions in Older Adults: A Nationwide Descriptive Cohort Study in Denmark20
Hallucinations, Antipsychotic Use, and Mortality in Older Adults with Dementia: Retrospective Cohort Study of Two Medicare-Linked National Health Surveys20
Use of Muscle Relaxants After Surgery in Traditional Medicare Part D Enrollees19
Real-World Drug Survival of Biologics and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs Among Patients with Psoriatic Arthritis19
Prescribing Appropriate Medicines to Older Adults: A Finnish Experience with the Web-Based Meds75+ Database19
Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review17
Geriatric Assessment in the Era of Targeted and Immunotherapy17
Elevating Safe Use of Over-The-Counter Medications in Older Adults: A Narrative Review of Pharmacy Involved Interventions and Recommendations for Improvement16
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders16
Temporal Trends Over Two Decades in the Use of Anticholinergic Drugs Among Older Community-Dwelling People in Helsinki, Finland16
Low-Dose Glucocorticoids in Older Patients with Rheumatoid Arthritis: What Does the Evidence Say?15
Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals15
The Association of Gabapentin Initiation with Cognitive and Behavioral Changes in Older Adults with Cognitive Impairment: A Retrospective Cohort Study15
Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities14
The Prognostic Utility of Anticholinergic Burden Scales: An Integrative Review and Gap Analysis13
Fall-Risk-Increasing Drugs and Gait Performance in Community-Dwelling Older Adults: Exploratory Results from the Gait and Brain Study13
Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options13
What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators13
Association between the Use of Suvorexant and Hip Fracture in Older Adults in Japan Using a Nationwide Administrative Claims Database: A Matched Case–Control Study12
Perioperative Anticholinergic Medication Use and Incident Dementia among Older Surgical Patients: a Retrospective Cohort Study using Real-World Data12
Benefit–Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous Thromboembolism12
Hormonal Agents for the Treatment of Depression Associated with the Menopause12
Medicine Optimisation and Deprescribing Intervention Outcomes for Older People with Dementia or Mild Cognitive Impairment: A Systematic Review12
Clinician and Family Caregiver Perspectives on Deprescribing Chronic Disease Medications in Older Nursing Home Residents Near the End of Life12
Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis12
Correction to: Hexanic Extract of Serenoa repens (Permixon®): A Review in Symptomatic Benign Prostatic Hyperplasia11
Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review11
Treating LUTS in Men with Benign Prostatic Obstruction: A Review Article11
Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity11
Efficacy and Safety of Oral P2Y12 Inhibitors in Older Patients with Acute Coronary Syndrome: A Frequentist Network Meta-Analysis11
Discontinuation of Loop Diuretics in Older Patients with Chronic Stable Heart Failure: A Narrative Review11
Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects10
A Cohort Study on Influenza Vaccine and All-Cause Mortality in Older Adults: Methodological Concerns and Public Health Implications10
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice10
Association of Potentially Inappropriate Medication Classes with Mortality Risk Among Older Adults Initiating Hemodialysis10
Pharmacotherapy for Spine-Related Pain in Older Adults10
Hormone Treatment and Alzheimer’s Disease: Déjà Vu or Confused All Over Again?10
Acknowledgement to Referees10
Correction to: A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 10
Safety Study of Anticoagulants for Preventing Deep Venous Thrombosis after Intracerebral Hemorrhage: Data from the Chinese Stroke Center Alliance10
Pharmacological Treatment in the Management of Glenohumeral Osteoarthritis10
Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India9
Minimising Harm and Managing Pain: Deprescribing Opioids in Older Adults9
HOSPITAL Score and LACE Index to Predict Mortality in Multimorbid Older Patients9
Authors’ Reply to Moura et al.: “Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk”9
Complement Mediators in Development to Treat Age-Related Macular Degeneration9
Fibromyalgia in Older Individuals9
Attitudes to Drug Use in Residential Aged Care Facilities: A Cross-Sectional Survey of Nurses and Care Staff9
Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia9
Correction to: The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation9
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?9
Patterns of Comorbidities and Prescribing and Dispensing of Non-steroidal Anti-inflammatory Drugs (NSAIDs) Among Patients with Osteoarthritis in the USA: Real-World Study8
Estimating the Time to Benefit for Therapies in Heart Failure with Reduced Ejection Fraction: A Case Study of Sacubitril-Valsartan Using Reconstructed Data from a Randomized Controlled Trial8
Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia8
Post-Stroke Depression in Older Adults: An Overview8
The Difficulties of Managing Pain in People Living with Frailty: The Potential for Digital Phenotyping8
Factors Associated with Psychotropic Medication Use in People Living with Dementia in the Community: A Systematic Review and Meta-Analysis8
Management of Scleritis in Older Adults8
Hypertension Treatment in Frail Older Adults: A Systematic Review and Appraisal of Guidelines8
Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults7
Measuring Quality of Life in Deprescribing Trials: A Scoping Review7
Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study7
TANGO: Development of Consumer Information Leaflets to Support TAperiNG of Opioids in Older Adults with Low Back Pain and Hip and Knee Osteoarthritis7
Considerations for Choosing First-Line Urate-Lowering Treatment in Older Patients with Comorbid Conditions7
A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults7
Do Proton Pump Inhibitors Reduce Upper Gastrointestinal Bleeding in Older Patients with Atrial Fibrillation Treated with Oral Anticoagulants? A Nationwide Cohort Study in France7
Medication Complexity Among Older Adults with HF: How Can We Assess Better?7
Safety and Tolerability of Antimicrobial Agents in the Older Patient6
Individualizing Antiretroviral Therapy in the Older Patient6
Prevalence of Adverse Drug Reactions in Hospital Among Older Patients with and Without Dementia6
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?6
Rho Kinase Inhibitors: Strategies in Glaucoma Treatment in Older Adults6
Pre-clinical Models for Geriatric Pharmacotherapy6
Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials6
Anticholinergic Exposure, Drug Dose and Postoperative Delirium: Comparison of Dose-Related and Non-Dose-Related Anticholinergic Burden Scores in a Retrospective Cohort Study of Older Orthopaedic and T6
Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models6
Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care6
Crushed Tablet Administration for Patients with Dysphagia and Enteral Feeding: Challenges and Considerations6
Acknowledgement to Referees6
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients6
Changes in Medication Complexity and Post-Hospitalization Outcomes in Older Adults Hospitalized for Heart Failure6
From Drugs to Dry Mouth: A Systematic Review Exploring Oral and Psychological Health Conditions Associated with Dry Mouth in Older Adults with Polypharmacy6
Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review6
Respiratory Syncytial Virus Infection in Older Adults: An Update6
Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care?5
Efficacy and Safety of Fixed-Dose Combinations for Pain in Older Adults5
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients5
Older Canadians’ Perceptions of the Safety, Effectiveness and Accessibility of Cannabis for Medicinal Purposes: A Cross-Sectional Analysis5
Inappropriate Combined Antiplatelet and Anticoagulant Therapy in Older Patients with Atrial Fibrillation: Trend over Time (2009–18)5
Evaluation and Treatment of Acute Trauma Pain in Older Adults5
Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma5
Development of a Frailty Screening Tool Using Electronic Community Pharmacy Records5
Opioid Prescriptions for Low Back Pain among Military-Connected Older Adults Across Multiple Care Systems5
Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder5
Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis5
Dosage Optimization of Digoxin in Older Patients with Heart Failure and Chronic Kidney Disease: A Population Pharmacokinetic Analysis5
A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes5
Helicobacter pylori Eradication Treatment in Older Patients5
Considerations for Anesthesia in Older Adults with Cannabis Use5
Pharmacological Pain Treatment in Older Persons5
Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)5
Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”5
Risk of Fractures in Older Adults with Chronic Non-cancer Pain Receiving Concurrent Benzodiazepines and Opioids: A Nested Case–Control Study5
Psychotropic Drug Prescription in Nursing Homes During the COVID-19 Pandemic5
Treating Hypertension in Older Adults in Light of the Recent STEP Trial: Can We Implement the Findings in Geriatric Practice?5
Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Decade of Experience5
Status Epilepticus in Older Adults: Diagnostic and Treatment Considerations4
Identifying Residents Who May Benefit from an Analgesic Review: Applying Analgesic Indicators in Residential Aged Care Services4
Relationship Between Frailty and Diabetic Pharmacologic Therapy in Older Adults with Type 2 Diabetes: A Cross-Sectional Study4
Pharmacological Risk Assessment Among Older Patients with Polypharmacy Using the Clinical Decision Support System Janusmed Risk Profile: A Cross-Sectional Register Study4
Correlates of Opioid Use Among Ontario Long-Term Care Residents and Variation by Pain Frequency and Intensity: A Cross-sectional Analysis4
Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of Coprescriptions4
Pharmacological Treatments for Presbyopia4
Correction to: SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction4
Ageing with HIV: Medicine Optimisation Challenges and Support Needs for Older People Living with HIV: A Systematic Review4
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer’s Disease Initiating Cholinesterase Inhibitors4
Psychotropic Medication Prescribing to Patients with Dementia Admitted to Acute Hospitals in Ireland4
Deprescribing Medications that Increase the Risk of Falls in Older People: Exploring Doctors' Perspectives Using the Theoretical Domains Framework (TDF)4
A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle Arrest4
Pilocarpine in the Treatment of Presbyopia: Progress, Issues, and Future Prospects4
Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing3
Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations3
Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes3
Safety and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Older Adults with Variable Disease States: A Meta-analysis of Large Placebo-Controlled Trials3
Platelet-Rich Plasma for Knee Osteoarthritis: What Does the Evidence Say?3
Topical Pharmacotherapy for Actinic Keratoses in Older Adults3
Executive Summary: Treatment of Osteoporosis and Osteoarthritis in the Oldest Old3
Opioids and Falls Risk in Older Adults: A Narrative Review3
Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial3
Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults3
Dementia Medications and Their Association with Pain Medication Use in Medicare Beneficiaries with Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Chronic Pain3
Evaluation of Renal Function Testing in Older Australian Veterans Dispensed Medicines that Require Renal Function Monitoring3
Management of Hypertension in the Elderly and Frail Patient3
Assessing Long-Term Adverse Outcomes in Older Kidney Transplant Recipients: A Propensity Score-Matched Comparison of Early Steroid Withdrawal Versus Continuous Steroid Immunosuppression Using a Large 3
Association of Tumor Necrosis Factor-α Inhibitors with Incident Dementia: Analysis Based on Population-Based Cohort Studies3
Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update3
Acknowledgement to Referees3
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany3
ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People3
Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Plati3
Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009–20203
Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies2
The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review2
Patient-Reported Outcomes in Geriatric Oncology—Balancing Quality of Life and Therapeutic Effectiveness Using Primary Breast Cancer as a Model2
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study2
The Relationship Between Antipsychotics, Cognitive Enhancers, and Major Adverse Cardiovascular/Cerebrovascular Events (MACCE) in Older Adults with Behavioral and Psychological Symptoms of Dementia2
Use of Hormone Therapy in Postmenopausal Women with Alzheimer’s Disease: A Systematic Review2
Management of Older Adults with Sickle Cell Disease: Considerations for Current and Emerging Therapies2
Associations Between Midlife Anticholinergic Medication Use and Subsequent Cognitive Decline: A British Birth Cohort Study2
Association of Psychotropic Education with Quality of Life: A Before-After Study in Residential Aged Care Facilities2
International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study2
Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older Patients2
Development of a Predictive Model for Potentially Inappropriate Medications in Older Patients with Cardiovascular Disease2
The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults2
Correction to: The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults2
MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice2
Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management2
Patient-Centric Approach for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease in Older People2
Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel for Elderly Chinese Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Retrospective Cohort Study2
Diagnosis and Management of Pain in Parkinson's Disease: A New Approach2
Aspiring to Reasonableness in Accelerated Approval: Anticipating and Avoiding the Next Aducanumab2
A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA2
Opioid Initiation and the Hazard of Falls or Fractures Among Older Adults with Varying Levels of Central Nervous System Depressant Burden2
New Horizons in the Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis2
Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study2
Correction: Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options2
Prevalence of Musculoskeletal Pain and Analgesic Treatment Among Community-Dwelling Older Adults: Changes from 1999 to 20192
Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross-sectional study2
Benefit–Risk Assessment of Psychotropic Drugs in Older Patients with Chronic Obstructive Pulmonary Disease2
Safety and Effectiveness of Immune Checkpoint Inhibitors in Older Patients with Cancer: A Systematic Review of 48 Real-World Studies2
Low-Income Older Adults’ Vulnerability to Anticholinergic Medication-Associated Frailty2
Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study2
Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial2
Hypotension Under Antihypertensive Treatment and Incident Hospitalizations of Nursing Home Residents2
Pharmacotherapeutic Management of Well-Differentiated Neuroendocrine Tumors in Older Patients: Current Status and Potential Therapies2
Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study2
An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 20192
0.18910694122314